Arctoris Celebrates 5th Anniversary and Launches Its Expanded Robotic Platform Ulysses

Ulysses is an advanced, fully automated robotic platform developed and operated by Arctoris that provides superior quality data and accelerates drug discovery.

Ulysses is an advanced, fully automated robotic platform developed and operated by Arctoris that provides superior quality data and accelerates drug discovery OXFORD, UK – 10 February 2021. Arctoris Ltd, an Oxford-based technology company operating a fully automated drug discovery platform, celebrated its 5th anniversary on the 4th of February. Over the past five years, Arctoris […]

Biology 2.0: Combining machine-learning, robotics and biology to deliver drug discovery of tomorrow

Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment OXFORD, UK – 17 December 2020. Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment Medicines discovery innovators, Intelligent OMICS, supported by Arctoris and Medicines Discovery Catapult, are applying artificial intelligence […]

Arctoris appoints three experienced industry executives as members of its Advisory Board

Joining Arctoris in senior roles are Beth J Hoffman PhD, Prof Khusru Asadullah MD and Stanley Lapidus (left to right) OXFORD, UK – 8 December 2020. Arctoris Ltd, an Oxford-based research company operating a fully automated drug discovery platform, has appointed three distinguished experts as members of its Advisory Board: Beth J Hoffman PhD, Professor Khusru […]

Arctoris and Syntekabio Form Research Partnership

Robot human handshake

Syntekabio and Arctoris join their forces in the fight against COVID-19. Together, they substantially accelerate drug discovery by combining their leading technologies: Syntekabio’s in silico modeling simulation and Arctoris’ fully-automated in vitro validation. OXFORD, UK – 8 September 2020. Arctoris, the creator of the world’s first fully automated drug discovery platform, has signed a Memorandum of […]

Insilico Medicine and Arctoris to collaborate on COVID-19 by combining robotics and AI

Insilico Medicine and Arctoris to collaborate on COVID-19 by combining robotics and AI (Credit: Insilico) OXFORD, UK – 09 July 2020. Insilico Medicine, a biotechnology company developing an end-to-end drug discovery pipeline utilizing next-generation artificial intelligence, today announced a technology partnership with Arctoris, the world’s first fully automated drug discovery platform, offering remotely accessible, pre-optimised and fully […]

Arctoris contributes its capabilities and expertise to the fight against COVID-19

OXFORD, UK – 07 July 2020. Arctoris Ltd. supports global research efforts to find new therapeutics against COVID-19. Scientists in academic centres and companies around the world desperately search for novel therapeutics and vaccines to treat and prevent COVID-19. However, with lockdowns and limited access to laboratories, researchers are being forced to work from home, putting research […]

BioTarget 2019 winners

BioTarget 2019 finalists compete in a pitch finale held in London, UK​ OXFORD, UK – 11 June 2019 Eight biotech companies from around the world were selected as finalists to compete for free experimentation worth $170,000 on the Arctoris robotic system. A distinguished panel – including Sonal Patel (VP, Oncology Lead, Johnson & Johnson), Jackie […]

Reproducibility film

Arctoris co-founder & CEO Martin-Immanuel Bittner features in a short film about reproducibility and open data in drug discovery​ OXFORD, UK – 19 June 2019 A short film about reproducibility and open data in drug discovery was officially released to the public in Berlin, Germany, at an event organised by the Young Academy of the […]

Arctoris secures £3.2M

Arctoris secures seed funding of £3.2 million to advance novel drug discovery platform powered by robotics​ OXFORD, UK – 30 September 2019 Arctoris Ltd today announced that it has successfully closed a seed funding round of £3.2 million to advance its novel drug discovery offering. The funding will be used to further build out the […]

Arctoris expands senior team

Arctoris strengthens senior team to continue the development of its on-demand drug discovery services​. Joining Arctoris in senior roles are Professor John Mattick, Member of the Board of Directors (left) & Dr Daniel Thomas, Head of Discovery Biology (right) OXFORD, UK – 13 November 2019 Arctoris Ltd today announced the appointment of Professor John Mattick AO FAA […]